|
02 Jul 2018 |
Social |
Metanalysis of 11 RCTs show that DMARDs and biologics are no better than Placebo in treating symptomatic Osteoarthritis https://t.co/OGwvaEglhZ |
|
|
27 Jun 2018 |
Social |
233,608 statin initiators not shown to increase the risk of hand osteoarthritis when compared 1:10 with non users (from UK Clinical Practice Research Datalink) https://t.co/FLQnfBAfdl |
|
|
21 Jun 2018 |
Social |
Metanalysis of 11 RCTs show that DMARDs and biologics are no better than Placebo in treating symptomatic Osteoarthritis https://t.co/OGwvaEglhZ |
|
|
16 Jun 2018 |
Social |
RT @DrAiLynTan: Secondary #osteoporosis in systemic mastocytosis!
Prevalence ~ 30%
Beware in cascade of multiple vertebral #fractures!
m… |
|
|
16 Jun 2018 |
Social |
Dr. David Felson shows bone marrow lesions correlate well with pain of osteoarthritis, and may improve either treatment. from #EULAR SP0152 https://t.co/Jy94IwdPYQ |
|
|
16 Jun 2018 |
Social |
Felson shows diastolic BP shows 2x risk of OA from #EULAR SP0152 |
|
|
15 Jun 2018 |
Social |
RT @DrAiLynTan: Osteonecrosis of the #jaw & antiresorptive treatments
statistics, prevalence & incidence
via Roux #EULAR2018
#ONJ #mand… |
|
|
15 Jun 2018 |
News |
Update on Osteoporosis |
|
|
13 Jun 2018 |
Social |
Denosumab (Prolia) was approved by the European commission for use in glucocorticoid induced osteoporosis (GIOP) for use in the EU. Timing is perfect given all the GIOP and SIOP abstracts presenting at #EULAR2018 https://t.co/isltyIwpfi |
|
|
13 Jun 2018 |
Social |
Curtis/Saag present data on 150,000 women on Bisphosphonates (BP); 40% d/c for >6mos. W/in 2 yrs theres a 20% incr risk of fracture, higher (40%) after 2 yrs, but less in prev Fosamax Rx pts #EULAR2018 @RheumNow OP0017 |
|
|
13 Jun 2018 |
Social |
RT @RonanTKavanagh: @Janetbirdope @RheumNow Especially if DXA hip osteoporosis. |
|
|
13 Jun 2018 |
Social |
RT @RonanTKavanagh: Minten. Low dose radiotherapy not effective for hand and knee OA. Patients randomised to low dose radiotherapy vs Sham… |
|
|
13 Jun 2018 |
Social |
RT @DrAiLynTan: Zolendronic acid
didn't significantly reduce cartilage volume loss, #knee pain or bone marrow lesion size in knee #osteoa… |
|
|
04 Jun 2018 |
Social |
JBMR reports a single center study showing that among 53 severe osteoporosis patients treated w/ teriparitide, hypomagnesemia was seen in 36% - risk factors include older age and lower baseline Mg levels. Consider monitoring Mg https://t.co/NUKwHjWkq8 |
|
|
03 Jun 2018 |
Social |
FDA approves the combo drug Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain - is this brilliant of an expensive brand of stupid? https://t.co/RZO0wOl6T8 |
|
|
25 May 2018 |
Social |
RheumNow Wk in Review is up! Hot news on CIRT, OP, MPO & what SLE will and wont do. Checkout podcast on iTUnes or here https://t.co/0vxHMCOfHD |
|
|
25 May 2018 |
News |
Restless Sleep and Inactivity Intertwined in OA |
|
|
22 May 2018 |
News |
FDA Approves Denosumab for Glucocorticoid-Induced Osteoporosis |
|
|
21 May 2018 |
Social |
The ration of BMD to BMI index predicts fracture risk - a new study 2225 obese pts presented at the 2018 annual American Association of Clinical Endocrinologists (AACE) meeting. https://t.co/0FDJX8xx0t |
|
|
17 May 2018 |
Social |
Osteoarthritis Initiative study of 1203 pts shows that running was not associated with worsening of knee pain or radiographic structural progression https://t.co/Y7UCTNMpKy |
|
